CompletedPhase 3NCT00351520

Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tehran University of Medical Sciences
Principal Investigator
Ali Khamesipour
Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences
Intervention
Miltefose(drug)
Enrollment
148 target
Eligibility
12-60 years · All sexes
Timeline
2006 – 2007

Study locations (1)

Collaborators

World Health Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00351520 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials